Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.

Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.

Item
http://www.wikidata.org/entity/Q30584978
Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models.Effect of low doses of actinomycin D on neuroblastoma cell linesCyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma.Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence.Low-Dose Actinomycin-D Induces Redistribution of Wild-Type and Mutated Nucleophosmin Followed by Cell Death in Leukemic Cells.Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma
P2860

Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.

Item
http://www.wikidata.org/entity/Q30584978
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterisation of the clinic ...... ition in children with cancer.
@ast
Characterisation of the clinic ...... ition in children with cancer.
@en
type
label
Characterisation of the clinic ...... ition in children with cancer.
@ast
Characterisation of the clinic ...... ition in children with cancer.
@en
prefLabel
Characterisation of the clinic ...... ition in children with cancer.
@ast
Characterisation of the clinic ...... ition in children with cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Characterisation of the clinic ...... ition in children with cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P932